Breast Cancer, Gastrointestinal Cancer, Gynecologic Cancer, Head and Neck Cancer, Lung Cancer, Prostate Cancer
Conditions
Brief summary
The purpose of this study is to improve cancer care and the delivery of cancer care. Researchers are interested in studying patient reported information and examining how different factors may impact cancer care.
Interventions
OTHERSurvey
Subjects will be asked to complete a survey asking questions about his/her current health, well-being and quality of life.
OTHERSaliva sample
Subjects will have saliva collected by a member of the study team using a cotton swab.
OTHERSmoking Status questions
Subjects will be asked to complete an assessment asking questions about his/her current smoking status
Sponsors
National Institutes of Health (NIH)
Medical University of South Carolina
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Diagnosed with head/neck, lung, breast, prostate, gastrointestinal or gynecologic cancer * 21 years of age or older at time of study registration * Must have been referred to MUSC radiation oncology for treatment with curative radiation therapy * Must report current smoking defined as self-reporting smoking within the past 30 days using a structured intake questionnaire.
Exclusion criteria
* Patients with primary central nervous system malignancies will be excluded. * Patients that have other cancer disease types will be excluded due to either significant differences in standard radiation therapy approaches or rarity of disease required radiation. * Patients who are currently participating in the Medical University of South Carolina Hollings Cancer Center smoking cessation program * Patients who are unable to provide informed consent
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Number of patients with biochemically confirmed smoking cessation | 4 weeks after enrollment | Biochemical confirmation will be determined by saliva samples |
| Number of patient who self-report smoking cessation | 4 weeks after enrollment | Self-reported smoking cessation will be documented via smoking assessment questionnaire |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Average weekly smoke exposure | up to 62 weeks | reported cigarettes per day multiplied by the number of days smoked during radiation therapy (RT), summed over a period of time and normalized to yield an average weekly smoke exposure during RT. |
| Number of patients who participate in smoking cessation | up to 12 months after completion of RT. | Completing one in-person visit where an individualized smoking cessation treatment plan is developed and implemented. |
| Compliance with smoking cessation | up to 12 weeks after completion of RT | Two binary measure of compliance: 1. \- completing at least three in person visits within 6 weeks of starting an individualized cessation treatment plan 2. \- completing at least one in-person visit and at least two phone-based communications |
Countries
United States
Outcome results
None listed